Blueprint Medicines Corp - Company Profile
Powered by 
All the sales intelligence you need on Blueprint Medicines Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Blueprint Medicines Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Blueprint Medicines Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Blueprint Medicines Corp’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 24 May 2023 | Blueprint Medicines Corp Enters Phase I/II Clinical Trial Agreement with PPD Inc for elenestinib (GDCT0471592) | Contract Service Agreement |
Blueprint Medicines Corp
|
PPD Inc |
| 10 Apr 2023 | Lengo Therapeutics to Raise Funds through Venture Financing | Venture Financing | - |
Lengo Therapeutics Inc (Inactive)
|
| 17 Feb 2023 | Blueprint Medicines to Raise Up to USD300 Million in Public Offering of Common Stock | Equity Offering | - |
Blueprint Medicines Corp |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer